Tag Archives: Data

ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom

Novo Nordisk’s semaglutide franchise has taken off in a big way. Type 2 diabetes med Ozempic smashed the blockbuster barrier in 2019, the same year the company launched its oral option, Rybelsus. Now, the Danish diabetes major is touting data on a higher-dose prospect. In a late-stage trial, Ozempic 2 mg trumped its 1-mg predecessor on blood… Read More »

From the Wastewater Drain, Solid Pandemic Data

The Coronavirus Outbreak liveLatest Updates Maps and Cases Vaccine Rollout Second Dose Outdoor Mask Guidance Advertisement Continue reading the main story Supported by Continue reading the main story From the Wastewater Drain, Solid Pandemic Data The coronavirus could turn sewage surveillance into a mainstream public health practice. Marc Johnson, a virologist at the University of… Read More »

Calligo Acquires Decisive Data to Accelerate Data Insights Services

Calligo rapidly expands its data science service capabilities, which combined with its established managed data privacy, security and data insights portfolio, creates a world leader in safe, intelligent, accessible data services St Helier, Jersey, 17 February 2021 – Calligo, the world’s first end-to-end managed data services provider, today announced it has acquired Decisive Data, a… Read More »

Data from routine clinical care shows people with HIV have an increased risk of dementia and that it’s diagnosed at a younger age

The risk of dementia in older age is increased by 58% for people living with HIV compared to their HIV-negative peers, according to US research published in the online edition of AIDS. The average age at dementia diagnosis was much younger for people with HIV: 67 years compared to 78 years for people without HIV.… Read More »

Pfizer’s much-anticipated COVID-19 vaccine data have yet to materialize. Can it still roll out this year?

With a bold prediction that interim data on its COVID-19 shot would be in the public’s hands by October, all eyes have been on Pfizer and CEO Albert Bourla. But with just days to go before November, those data still aren’t available—and Pfizer is holding on to hope that it can still roll out the… Read More »